Epidemiology
Japanese Encephalitis was fi rst confi rmed in western part of Nepal in 1978. 4 Since then, Japanese Encephalitis has been confirmed in 54 districts of Nepal. 1777 cases of Japanese Encephalitis has been serologically confirmed in Nepal from [2004] [2005] [2006] [2007] . It is important to remember that Japanese Encephalitis is an under reported disease. For every reported JE case, there are approximately 300 asymptomatic cases. 5 This means that upwards of 533, 100 people were infected with this disease during 2004-2007, mostly amongst residents of rural areas. Incubation period of Japanese encephalitis varies, but 5-15 days is typical.
Japanese Encephalitis has been confi rmed in all age groups in Nepal. Almost 50 % of the cases are 15 year or younger in age. The highest incidence rate is in the age group of 5-15 years. Japanese encephalitis is more common in males than in females, probably due to greater exposure during the mosquitoes feeding hours.
6,7 Almost 60% of the cases occur in males.
Japanese Encephalitis has been reported from all eco-regions of the country. The majority of JE cases occur in the Terai. Table 1 . Japanese Encephalitis is not a year around disease in Nepal like in other countries of South Asia. Incidence of JE is highest between July to September each year. The outbreaks occur after monsoon and coincide with Acute Encephalitis Syndrome outbreaks. The outbreak peaks during August. Limited number of Japanese Encephalitis cases is then reported from November to March. This seasonal phenomenon is demonstrated in Figure 2 . 5 Japanese Encephalits is a killer and a debilitating disease. The mortality rate from Japanese Encephalitis in Nepal is 13.2% 6 and falls with in the described range of 0.3% to 60% and depends on the population and on age. Out of the surviving, up to 30% may develop some type of permanent neurological debility and about 10% recover to pre infective status. 8 
Summary
Every person in Nepal is at risk against Japanese Encephalitis. High mortality and disability rate has made Japanese encephalitis a disease of public health priority. Government of Nepal has responded to the challenge by expanding the surveillance network and is working closely with district health system to improve the sensitivity of the surveillance system. Mass immunization campaign followed by introduction of the vaccine in routine immunization will signifi cantly reduce the threats posed by the disease in Nepal. SA-14-14-2 is a very safe and effective vaccine, and at present it is the vaccine of choice for introduction into the National Immunization Program.
